Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Baker Felix
Relationship:   Director, 10% Owner
City:  
State:  
   
Insider Summary:
  
   
Companies Owned :   20    
Direct Shares   927,207    

Indirect Shares

   141,861,898      
Direct Value   $84,286,221    

Indirect Value

   $13,081,599,865      
Total Shares   142,789,105      
Total Value   $13,165,886,086      


Incyte Corp $34,779,302 Seagen Inc $49,182,531 Synageva BioPharma Corp $0 Genomic Health Inc $18,271 Biocryst Pharmaceuticals Inc $289,484 Neurogene $16,634 Incyte Corp $34,779,302 Seagen Inc $49,182,531 Synageva BioPharma Corp $0 Genomic Health Inc $18,271 Biocryst Pharmaceuticals Inc $289,484 Neurogene $16,634
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    36   
    6    

     Stock price went up :
    15   
    6    
     Stock price went down :
    21   
    0    
   
     Gain/Loss Ratio :
   0.0   
   6.0   
     Percentage Gain/Loss :
   -24.3%
 18.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Incyte Corp INCY Director, 10% Owner 2023-09-29 559,963 2023-09-29 33,480,292    Premium*  
            Ardea Biosciences Inc RDEA Director, 10% Owner 2003-10-06 0 2012-02-01 116,454    Premium*  
            Seagen Inc SGEN Director, 10% Owner 2018-02-01 215,015 2018-02-01 44,355,335    Premium*  
            Synageva BioPharma Corp GEVA Director, 10% Owner 2015-06-22 100,503 2015-06-22 9,328,233    Premium*  
            Viropharma Inc VPHM 10% Owner 2005-01-31 0 2011-12-14 303,264    Premium*  
            Aceragen, Inc ACGN Director 0 2017-07-03 145,453    Premium*  
            Tapestry Pharmaceuticals Inc TPPHQ 10% Owner 0 2008-10-15 0    Premium*  
            Genomic Health Inc GHDX Director, 10% Owner 2012-10-01 288 2012-10-01 11,377,485    Premium*  
            Allos Therapeutics Inc ALTH 10% Owner 0 2009-02-06 1,629    Premium*  
            Biocryst Pharmaceuticals Inc BCRX 10% Owner 2016-08-16 46,918 2016-08-16 9,418,390    Premium*  
            Heron Therapeutics Inc HRTX 10% Owner 0 2011-06-30 5,266,568    Premium*  
            Adolor Corp ADLR 10% Owner 2010-04-26 0 2011-12-19 0    Premium*  
            Diadexus Inc DDXS 10% Owner 0 2010-07-28 140,525    Premium*  
            Pharmacyclics Inc PCYC 10% Owner 0 2011-08-22 1,809    Premium*  
            Ocera Therapeutics Inc OCRX 10% Owner 2012-03-12 0 2012-03-14 57,704    Premium*  
            XOMA Corporation XOMA Director, 10% Owner 2012-10-29 0 2012-10-29 480,639    Premium*  
            Neurogene NGNE 10% Owner 2015-08-07 4,520 0    Premium*  
            Invitae Corp NVTA 10% Owner 0 2015-08-27 6,554,967    Premium*  
            Bellicum Pharmaceuticals, Inc BLCM 10% Owner 0 2015-12-24 4,865,647    Premium*  
            Kodiak Sciences Inc. KOD Director, 10% Owner 2022-01-21 0 2022-06-06 15,967,504    Premium*  
* Premium Members only  

Records found :    1397         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 16 of 56
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
BCRX Biocryst Pharmaceuticals ... 10% Owner   –       –       •   2016-01-15 4 B $7.45 $1,491,223 I/I 200,000 12,301,485 1.5 -
BCRX Biocryst Pharmaceuticals ... 10% Owner   –       –       •   2016-01-19 4 B $7.12 $656,750 I/I 92,200 12,393,685 1.5 -
BCRX Biocryst Pharmaceuticals ... 10% Owner   –       –       •   2016-01-20 4 B $6.87 $362,171 I/I 52,695 12,446,380 1.5 -
BCRX Biocryst Pharmaceuticals ... 10% Owner   –       –       •   2016-01-21 4 B $7.29 $755,368 I/I 103,600 12,549,980 1.5 -
BCRX Biocryst Pharmaceuticals ... 10% Owner   –       –       •   2016-01-22 4 B $7.00 $22,389 I/I 3,200 12,553,180 1.5 -
BCRX Biocryst Pharmaceuticals ... 10% Owner   –       –       •   2016-01-27 4 B $6.98 $441,971 I/I 63,345 12,616,525 1.5 -
BCRX Biocryst Pharmaceuticals ... 10% Owner   –       –       •   2016-01-28 4 B $6.88 $172,015 I/I 25,000 12,641,525 1.5 -
BCRX Biocryst Pharmaceuticals ... 10% Owner   –       –       •   2016-02-02 4 B $6.52 $598,360 I/I 91,728 12,733,253 1.5 -
BCRX Biocryst Pharmaceuticals ... 10% Owner   –       –       •   2016-02-03 4 B $6.29 $573,311 I/I 91,187 12,824,440 1.5 -
BCRX Biocryst Pharmaceuticals ... 10% Owner   –       –       •   2016-02-04 4 B $6.65 $164,915 I/I 24,800 12,849,240 1.5 -
BCRX Biocryst Pharmaceuticals ... 10% Owner   –       –       •   2016-02-05 4 B $6.33 $284,657 I/I 45,000 12,894,240 1.5 -
BCRX Biocryst Pharmaceuticals ... 10% Owner   –       –       •   2016-08-12 4 S $5.00 $18,315,817 I/I (3,645,600) 9,762,823 0 -
BCRX Biocryst Pharmaceuticals ... 10% Owner   –       –       •   2016-08-15 4 S $4.83 $1,931,040 I/I (400,000) 9,419,240 0 -
BCRX Biocryst Pharmaceuticals ... 10% Owner   –       –       •   2016-08-16 4 S $4.29 $4,246 I/I (990) 9,418,390 0 -
BLCM Bellicum Pharmaceuticals,... 10% Owner   –       –       •   2015-12-24 3 IO $0.00 $0 I/I 0 4,865,647 -
DDXS Diadexus Inc 10% Owner   –       –       •   2010-07-28 3 IO $0.00 $0 I/I 0 140,525 -
DDXS Diadexus Inc 10% Owner   –       –       •   2010-07-28 3 IO $0.00 $0 I/I 0 198,140 -
DDXS Diadexus Inc 10% Owner   –       –       •   2010-07-28 3 IO $0.00 $0 I/I 0 57,631 -
DDXS Diadexus Inc 10% Owner   –       –       •   2010-07-28 3 IO $0.00 $0 I/I 0 4,567,055 -
DDXS Diadexus Inc 10% Owner   –       –       •   2010-07-28 3 IO $0.00 $0 I/I 0 2,306,025 -
GEVA Synageva BioPharma Corp Director   –       •       •   2004-09-10 4 B $12.55 $82,673 I/I 6,576 323,576 2.25 -
GEVA Synageva BioPharma Corp Director   –       •       •   2004-09-10 4 B $12.55 $410,220 I/I 32,630 1,215,554 2.25 -
GEVA Synageva BioPharma Corp Director   –       •       •   2004-09-10 4 B $12.55 $439,185 I/I 34,934 1,691,130 2.25 -
GEVA Synageva BioPharma Corp Director   –       •       •   2004-09-10 4 B $12.55 $51,658 I/I 4,109 282,109 2.25 -
GEVA Synageva BioPharma Corp Director   –       •       •   2004-09-13 4 B $13.56 $45,572 I/I 3,361 326,937 2.25 -
  1397  Records found
  1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16  17   18   19   20   21   22   23   24   25   26   27   28   29   30   31   32   33   34   35   36   37   38   39   40   41   42   43   44   45   46   47   48   49   50   51   52   53   54   55   56      
  Page 16 of 56  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us